Sinovac Biotech Ltd (SVA) shareholders
SVANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Jun 5, 2026Score 7/30
$6.47+0.00 (0.00%)
Close on Nov 16, 2026Market cap $464.94MP/E –Yield 850.08%
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
14.6%
10M of 72M shares
Institutional holders
29
4 new, 2 sold out
Net institutional buying
-0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| 1Globe Biomedical (Hong Kong) Company Limited Joint filing with 1Globe Capital LLC (32.30%) | 18,515,315 | 32.30% | 13D (active) amendment | Jul 7, 2025 |
| 1Globe Capital LLC Joint filing with 1Globe Biomedical (Hong Kong) Company Limited (32.30%), Jiaqiang Li (32.30%) | 18,515,315 | 32.30% | 13D (active) amendment | Sep 10, 2025 |
| Saif Iv Gp L.P. Joint filing with SAIF Partners IV L.P. (15.00%), SAIF IV GP Capital Ltd. (15.00%) | 10,780,820 | 15.00% | 13D (active) amendment | Feb 18, 2025 |
| SAIF IV GP Capital Ltd. Joint filing with SAIF Partners IV L.P. (15.00%), Saif Iv Gp, L.P. (15.00%) | 10,780,820 | 15.00% | 13D (active) amendment | Dec 15, 2025 |
| Saif Iv Gp, L.P. Joint filing with SAIF Partners IV L.P. (15.00%), SAIF IV GP Capital Ltd. (15.00%) | 10,780,820 | 15.00% | 13D (active) amendment | Jul 10, 2025 |
| SAIF Partners IV L.P. Joint filing with Saif Iv Gp, L.P. (15.00%), SAIF IV GP Capital Ltd. (15.00%) | 10,780,820 | 15.00% | 13D (active) amendment | Jun 16, 2025 |
| Weidong Yin | 6,359,500 | 8.85% | 13D (active) amendment | Jul 10, 2025 |
| Advantech Capital Partners Ltd. Joint filing with Advantech Capital L.P. (8.14%), Green Vision Partners Limited (8.14%) and 1 more | 5,851,423 | 8.14% | 13D (active) amendment | Jul 8, 2025 |
| Vivo Capital IX, LLC | 4,541,764 | 6.30% | 13D (active) amendment | Jul 11, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of SVA | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Vivo Capital, LLC | 5,903,000 | 8.21% | $38.19M | – | 3.49% |
| Orbimed Advisors LLC | 2,718,735 | 3.78% | $184.47M | – | 3.42% |
| Renaissance Technologies LLC | 1,312,520 | 1.83% | $0 | – | 0.00% |
| Neumann Advisory Hong Kong Ltd | 315,586 | 0.44% | $2.04M | – | 0.57% |
| California Public Employees Retirement System | 68,732 | 0.10% | $0 | – | 0.00% |
| Skandinaviska Enskilda Banken AB (publ) | 40,000 | 0.06% | $0 | −40,000 | 0.00% |
| Spark Investment Management LLC | 29,100 | 0.04% | $0 | – | 0.00% |
| Geode Capital Management, LLC | 27,717 | 0.04% | $0 | – | 0.00% |
| Susquehanna International Group, Llp | 16,430 | 0.02% | $106.30K | – | 0.00% |
| Navellier & Associates Inc | 13,018 | 0.02% | $0 | New | 0.00% |
| Morgan Stanley | 9,146 | 0.01% | $59.17K | +2 | 0.00% |
| Wells Fargo & Company/Mn | 4,580 | 0.01% | $29.63K | −231 | 0.00% |
| UBS Group AG | 2,479 | 0.00% | $16.04K | +250 | 0.00% |
| Osaic Holdings, Inc. | 1,001 | 0.00% | $0 | −1,200 | 0.00% |
| Atlantic Edge Private Wealth Management, LLC | 1,000 | 0.00% | $0 | – | 0.00% |
| Northwestern Mutual Wealth Management Co | 1,000 | 0.00% | $0 | – | 0.00% |
| Clearstead Advisors, LLC | 500 | 0.00% | $0 | – | 0.00% |
| Royal Bank of Canada | 426 | 0.00% | $0 | – | 0.00% |
| Tower Research Capital LLC (TRC) | 424 | 0.00% | $0 | – | 0.00% |
| Integrated Wealth Concepts LLC | 366 | 0.00% | $0 | New | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 29 | 10M | 14.6% | 4 / 3 | 5 / 2 | 0M | 0M |
| Q1 2026 | 28 | 10M | 14.6% | 3 / 4 | 2 / 3 | 0M | 0M |
| Q4 2025 | 28 | 10M | 14.6% | 1 / 3 | 3 / 0 | 0M | 0M |
| Q3 2025 | 27 | 10M | 14.6% | 2 / 6 | 1 / 2 | 0M | 0M |
| Q2 2025 | 28 | 10M | 14.6% | 26 / 0 | 0 / 0 | 7M | 0M |
| Q1 2025 | 3 | 3M | 4.2% | 1 / 0 | 0 / 1 | 0M | 0M |
| Q4 2024 | 4 | 3M | 4.2% | 0 / 0 | 0 / 5 | 0M | 12M |
| Q3 2024 | 9 | 15M | 20.8% | 1 / 1 | 0 / 17 | 0M | 1M |
| Q2 2024 | 26 | 16M | 22.8% | 2 / 2 | 6 / 2 | 0M | 0M |
| Q1 2024 | 26 | 17M | 23.0% | 18 / 1 | 1 / 0 | 13M | 0M |
| Q4 2023 | 8 | 3M | 4.3% | 0 / 1 | 2 / 22 | 0M | 9M |
| Q3 2023 | 30 | 12M | 16.5% | 1 / 3 | 1 / 0 | 0M | 0M |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Yin Weidong | Chief Executive Officer, Director | 6,359,500 | 8.85% | Mar 18, 2026 |
| Guang (Helen) Yang | Chief Business Officer | 172,900 | 0.24% | Mar 18, 2026 |
| Nan Wang | Chief Financial Officer | 355,000 | 0.49% | Mar 18, 2026 |
| Jing (Nmn) Li | VP, Quality and Production | 227,500 | 0.32% | Mar 18, 2026 |
| Qiang (Nmn) Gao | Chief Operation Officer | 230,000 | 0.32% | Mar 18, 2026 |
| Jiaqiang Li | Director | 18,515,315 | 25.77% | Apr 17, 2026 |
| Yuk Lam Lo | Director | 90,000 | 0.13% | Mar 18, 2026 |
| Simon Anderson | Director | 70,000 | 0.10% | Mar 18, 2026 |
| Yu Min Qiu | Director | – | – | Mar 18, 2026 |
| Shan Fu | Director | 5,903,000 | 8.21% | Mar 18, 2026 |
| Shuge Jiao | Director | – | – | Mar 18, 2026 |
| Yu (Nmn) Wang | Director | – | – | Mar 18, 2026 |
| Andrew Y. Yan | Director | 10,780,820 | 15.00% | Mar 18, 2026 |
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Short % of float
0.33%
0M shares short
Days to cover
1000.0
Change since last report
0.0%
From 0M shares
Short volume, 0 days
–
Of volume reported to FINRA
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Sinovac Biotech's stock actually held short. No settlement fails above the SEC's reporting threshold in the last 90 days.
See a number that looks wrong?